Supreme Court of Appeal blocks Monsanto’s GMO maize, citing flaws in government safety oversight
A Supreme Court of Appeal decision halts the release of genetically modified maize, pointing to ignored environmental ...
Kenya has robust system in place to manage GMOs: National Biosafety Authority
Kenya said Friday that it has a strong system in place to manage genetically modified organisms GMOs and related products In a statement issued in ...
business6d
GMO –Matters arising
MENSAH Given the controversies and broad spectrum of interests surrounding genetic engineering in agriculture, it is not surprising that different countries have developed and adopted diverse ...
Ag Funder News2d
Impossible Foods’ heme protein is safe, says EFSA GMO panel
EFSA's GMO panel has issued a positive opinion on the safety of Impossible Foods’ flagship heme protein ingredient.
manilatimes3d
Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE1831 in IgG4-Related Disease
IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program ACE1831 is an allogeneic gamma delta T cell therapy candidate targeting CD20-expressing ...
Computer Weekly3d
Nvidia powers AI development in Japan and Indonesia
Nvidia is deepening its presence in Japan and Indonesia through partnerships with local cloud providers and tech companies to ...
Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effectMarks ...
manilatimes6d
OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
OrganOx Ltd., a medical technology company developing innovative solutions for organ preservation, and eGenesis, Inc., a ...
Dyne Therapeutics Reveals Q3 Results and Trial Updates
Dyne Therapeutics, Inc. ( (DYN) ) has released its Q3 earnings. Here is a breakdown of the information Dyne Therapeutics, Inc. presented to its ...
Dupixent® (Dupilumab) Sbla Accepted For FDA Review For The Treatment Of Chronic Spontaneous Urticaria (CSU)
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity M ...
The Cool Down on MSN2d
Scientists are making headway in gene editing to unlock critical potential within trees: 'These findings ... lay the groundwork for further innovations'
Scientists and engineers at North Carolina State University have discovered trees can be used to produce greener, ...